{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:51:07Z","timestamp":1771674667555,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1093\/annonc\/mdq299","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T16:14:57Z","timestamp":1277309697000},"page":"1563-1565","source":"Crossref","is-referenced-by-count":17,"title":["Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma"],"prefix":"10.1016","volume":"21","author":[{"given":"M.","family":"Kodaira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saotome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yonese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq299_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/mdq299_bb0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jjco\/hym095","article-title":"Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma","volume":"37","author":"Akaza","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1093\/annonc\/mdq299_bb0020","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq299_bb0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2006.10.981","article-title":"Sorafenib induced erythema multiforme","volume":"56","author":"MacGrecor","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1093\/annonc\/mdq299_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/15569520902915469","article-title":"Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma","volume":"28","author":"Bilac","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1093\/annonc\/mdq299_bb0035","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1111\/j.1365-2230.2009.03320.x","article-title":"Erythema multiforme induced by sorafenib","volume":"34","author":"Feltes","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1093\/annonc\/mdq299_bb0040","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1200\/JCO.2008.21.7679","article-title":"Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity","volume":"27","author":"Van Erp","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq299_bb0045","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2008.20.8793","article-title":"Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics","volume":"27","author":"Gandara","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419394967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419394967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/7\/1563\/393183\/mdq299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T08:01:42Z","timestamp":1624521702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419394967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0923753419394967"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq299","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}